Table 2 Clinical, laboratorial, treatment data and PET findings in c-TA patients—groups 1 and 2 (15 patients)

Disease duration, years

11.0 (7.1–12.1)

8.1 (3.8–13.5)

Diagnosis delay, months

11.0 (3.0–27.0)

20.5 (1.6–41.3)

ESR, mm in 1st hour

8.0 (4.5–15.5)

4.5 (2.8–13.8)

CRP, mg/L

2.7 (0.3–15.9)

3.1 (1.6–6.3)

Angiographic type V, N (%)

5 (55.6)

0

SUVmax

3.4 (3.1–4.3)

3.1 (2.5–3.9)

MIV, cm³

2346 (1438–3304)

1177 (869–1880)

PETVAS

21.0 (19.0–26.0)

21.5 (21.0–25.0)

Prednisone, N (%)

4 (44)

1 (16.7)

Biologics, N (%)

4 (44)

2 (33.3)